<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="ru">
	<id>https://transhumanist.ru/index.php?action=history&amp;feed=atom&amp;title=EFEMP1</id>
	<title>EFEMP1 - История изменений</title>
	<link rel="self" type="application/atom+xml" href="https://transhumanist.ru/index.php?action=history&amp;feed=atom&amp;title=EFEMP1"/>
	<link rel="alternate" type="text/html" href="https://transhumanist.ru/index.php?title=EFEMP1&amp;action=history"/>
	<updated>2026-04-08T01:27:37Z</updated>
	<subtitle>История изменений этой страницы в вики</subtitle>
	<generator>MediaWiki 1.43.6</generator>
	<entry>
		<id>https://transhumanist.ru/index.php?title=EFEMP1&amp;diff=6454&amp;oldid=prev</id>
		<title>OdysseusBot: Новая страница: «EGF-containing fibulin-like extracellular matrix protein 1 precursor (Extracellular protein S1-5) (Fibrillin-like protein) (Fibulin-3) (FIBL-3) [FBLN3] [FBNL]  ==...»</title>
		<link rel="alternate" type="text/html" href="https://transhumanist.ru/index.php?title=EFEMP1&amp;diff=6454&amp;oldid=prev"/>
		<updated>2021-05-12T15:31:23Z</updated>

		<summary type="html">&lt;p&gt;Новая страница: «EGF-containing fibulin-like extracellular matrix protein 1 precursor (Extracellular protein S1-5) (Fibrillin-like protein) (Fibulin-3) (FIBL-3) [FBLN3] [FBNL]  ==...»&lt;/p&gt;
&lt;p&gt;&lt;b&gt;Новая страница&lt;/b&gt;&lt;/p&gt;&lt;div&gt;EGF-containing fibulin-like extracellular matrix protein 1 precursor (Extracellular protein S1-5) (Fibrillin-like protein) (Fibulin-3) (FIBL-3) [FBLN3] [FBNL]&lt;br /&gt;
&lt;br /&gt;
==Publications==&lt;br /&gt;
&lt;br /&gt;
{{medline-entry&lt;br /&gt;
|title=A novel age-related venous amyloidosis derived from [[EGF]]-containing fibulin-like extracellular matrix protein 1.&lt;br /&gt;
|pubmed-url=https://pubmed.ncbi.nlm.nih.gov/30565683&lt;br /&gt;
|abstract=Most intractable tissue-degenerative disorders share a common pathogenic condition, so-called proteinopathy. Amyloid-related disorders are the most common proteinopathies and are characterized by amyloid fibril deposits in the brain or other organs. Aging is generally associated with the development of these amyloid-related disorders, but we still do not fully understand how functional proteins become pathogenic amyloid deposits during the human aging process. We identified a novel amyloidogenic protein, named epidermal growth factor-containing fibulin-like extracellular matrix protein 1 ([[EFEMP1]]), in massive venous amyloid deposits in specimens that we obtained from an autopsied patient who died of gastrointestinal bleeding. Our postmortem analyses of additional patients indicate that [[EFEMP1]] amyloid deposits frequently developed in systemic venous walls of elderly people. [[EFEMP1]] was highly expressed in veins, and aging enhanced venous [[EFEMP1]] expression. In addition, biochemical analyses indicated that these venous amyloid deposits consisted of C-terminal regions of [[EFEMP1]]. In vitro studies showed that C-terminal regions formed amyloid fibrils, which inhibited venous tube formation and cell viability. [[EFEMP1]] thus caused a novel age-related venous amyloid-related disorder frequently found in the elderly population. Understanding [[EFEMP1]] amyloid formation provides new insights into amyloid-related disorders occurring during the aging process. Copyright © 2018 Pathological Society of Great Britain and Ireland. Published by John Wiley&lt;/div&gt;</summary>
		<author><name>OdysseusBot</name></author>
	</entry>
</feed>